Bio-Rad Labs (BIO) Tops Q2 EPS by 37c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $376.41 -1.57%
EPS Growth %: -1.3%
Financial Fact:
Net income per share basic attributable to Bio-Rad: 0.61
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -1.3%
Financial Fact:
Net income per share basic attributable to Bio-Rad: 0.61
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $1.64, $0.37 better than the analyst estimate of $1.27. Revenue for the quarter came in at $575.9 million versus the consensus estimate of $548.43 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Amneal gets FDA approval for lanreotide injection, launches immediately
- UBS cuts KOSPI target by nearly 10% to reflect higher rates
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
